雪天盐业：2025年前三季度净利润约3263万元

Group 1 - The core viewpoint of the article highlights the significant decline in the financial performance of Xue Tian Salt Industry in Q3 2023, with revenue dropping by 21.99% year-on-year to approximately 3.244 billion yuan and net profit decreasing by 90.37% to around 32.63 million yuan [1][1][1] - The basic earnings per share for the company fell to 0.0198 yuan, reflecting a year-on-year decrease of 90.3% [1][1][1] Group 2 - The article also mentions the broader context of the Chinese innovative pharmaceutical market, noting that overseas licensing deals have generated sales of 80 billion USD this year, indicating a robust secondary market for biomedicine [1][1][1] - A conversation with Lu Gang, a partner at Chuangdong Investment, points out the contrast between the hot secondary market and the cooling fundraising environment in the primary market for biomedicine [1][1][1]